Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of head and neck

  1. Hitt, R.
  2. Irigoyen, A.
  3. Cortes-Funes, H.
  4. Grau, J.J.
  5. García-Sáenz, J.A.
  6. Cruz-Hernandez, J.J.
Journal:
Annals of Oncology

ISSN: 0923-7534,  1569-8041

Year of publication: 2012

Volume: 23

Issue: 4

Pages: 1016-1022

Type: Article

DOI: 10.1093/ANNONC/MDR367 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus